NCT03849651
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +33 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Clinical trial condition
Leukemia, Myeloid
Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.
3,102 public trials
617 recruiting studies
Leukemia, Myeloid trial results
Active, Not Recruiting
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States
- University of California, Davis - Health Systems Sacramento, California, United States
- H Lee Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations
NCT04409639
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia (CMML), +11 more
- Locations
-
- Oregon Health and Science University Portland, Oregon, United States
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Active, Not Recruiting
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
NCT05589896
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +39 more
- Locations
-
- City of Hope Duarte, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University - Winship Cancer Institute Atlanta, Georgia, United States
- Henry Ford Cancer Institute Detroit, Michigan, United States
Active, Not Recruiting
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
NCT03190915
- Conditions
- Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +22 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center Downey, California, United States
Active, Not Recruiting
Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
NCT04655755
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
NCT03516279
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +15 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
Active, Not Recruiting
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
NCT03817398
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, +12 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)
NCT05233618
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +16 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
- University of Virginia Charlottesville, Virginia, United States
Active, Not Recruiting
CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
NCT04231851
- Conditions
- Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Hematologic Diseases, +6 more
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States
- University of California, Davis Sacramento, California, United States
- University of California, San Francisco San Francisco, California, United States